NL

Nicole Lai

Investment Consultant at Legal & General Capital

London, England

Overview 

Nicole Lai is a Health and Science Investor in London, England, with a background in Laboratory Skills and a Master's degree in Integrated Program in Neuroscience. She has held key roles at prominent firms like Legal & General Capital and has invested in various companies in sectors like Impact, DeepTech, Health & Hospital Services, and Health IT. Nicole Lai's career highlights include serving as an Angel Investor at multiple firms, such as Cherry Ventures and Atomico, and holding positions as a Board Observer at companies like FabricNano and Kheiron Medical.

Work Experience 

  • Investment Consultant

    2024 - Current

    Direct healthcare/deep tech growth investor and institutional LP fund investments

  • Angel Investor

    2022

    Investments include: Crade.bio, Mytos, Enginzyme, Effra

  • Investor

    2021 - 2023

  • Investor

    2019 - 2021

  • Board Observer

    2021 - 2021

  • Investor

    2020 - 2021

  • Board Observer

    2019 - 2021

  • Board Observer

    2019 - 2021

  • Investor

    2018 - 2019

  • Partner Associate

    2017 - 2019

    Real is an early-stage venture capital firm that backs entrepreneurs and builds the ecosystems in which they thrive. Real backs world-class entrepreneurs building game-changing companies, connecting them to local and national ecosystems and helping guide them through their next stages of evolution. The firm invests throughout the life-cycle of early-stage companies and provides stage-appropriate capital and support for the founders it backs. Real believes that VCs should play a role in accelerating the creation of world-class tech ecosystems by providing support beyond the companies for whom it writes cheques. It’s this collaborative mindset that inspires Real to launch initiatives that lay, or build upon, the foundations of rapidly growing tech hubs in Canada, and wherever else the firm may go.

Articles About Nicole

Relevant Websites